A detailed history of Mirabaud & Cie Sa transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mirabaud & Cie Sa holds 37,529 shares of MRK stock, worth $3.62 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
37,529
Previous 44,270 15.23%
Holding current value
$3.62 Million
Previous $5.48 Billion 22.24%
% of portfolio
1.23%
Previous 1.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$111.15 - $128.97 $749,262 - $869,386
-6,741 Reduced 15.23%
37,529 $4.26 Billion
Q2 2024

Oct 15, 2024

SELL
$123.8 - $132.96 $381,923 - $410,181
-3,085 Reduced 6.51%
44,270 $5.48 Billion
Q1 2024

Oct 15, 2024

SELL
$113.24 - $131.95 $551,365 - $642,464
-4,869 Reduced 9.32%
47,355 $6.25 Billion
Q4 2023

Sep 30, 2024

BUY
$100.18 - $109.02 $5.23 Million - $5.69 Million
52,224 New
52,224 $5.69 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mirabaud & Cie Sa Portfolio

Follow Mirabaud & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabaud & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Mirabaud & Cie Sa with notifications on news.